about
Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trendsInteraction between the 2'-5' oligoadenylate synthetase-like protein p59 OASL and the transcriptional repressor methyl CpG-binding protein 1Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancerMolecular constituents of the extracellular matrix in rat liver mounting a hepatic progenitor cell response for tissue repair.Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.Loss of c-Met disrupts gene expression program required for G2/M progression during liver regeneration in miceEpigenetic reprogramming modulates malignant properties of human liver cancer.Progenitor-derived hepatocellular carcinoma model in the rat.Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitorsAntitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2.MYC activates stem-like cell potential in hepatocarcinoma by a p53-dependent mechanism.Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancerAn integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancerLoss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic propertiesHuman hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways.Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway.Liver cancer oncogenomics: opportunities and dilemmas for clinical applications.Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer.A Gene Expression Signature Associated with Overall Survival in Patients with Hepatocellular Carcinoma Suggests a New Treatment Strategy.Transcriptional, post-transcriptional and chromatin-associated regulation of pri-miRNAs, pre-miRNAs and moRNAs.Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotypemTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma.UBE1L causes lung cancer growth suppression by targeting cyclin D1.Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types.Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits.A perspective on molecular therapy in cholangiocarcinoma: present status and future directions.Next-generation sequencing: application in liver cancer-past, present and future?Molecular pathogenesis of intrahepatic cholangiocarcinoma.Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts.Functional and genetic deconstruction of the cellular origin in liver cancer.High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy.Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).Molecular Pathogenesis and Current Therapy in Intrahepatic Cholangiocarcinoma.Molecular profiling of intrahepatic cholangiocarcinoma: the search for new therapeutic targets.Epigenome dysregulation in cholangiocarcinoma.Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual Conference.Role of 2-5A-dependent RNase-L in senescence and longevity.An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer.Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas.
P50
Q26830194-DB555D47-4020-4F2B-B84D-6ABF91EBB609Q28239188-8EF289C8-5E76-4822-BC6E-2C4498BA8127Q28384157-5520FFCC-2FEB-4067-B509-CDF4F3A7B8E0Q30564424-EB76ECBE-EAB1-4EE0-AE95-B737C4D7959CQ32173000-1DBEF0D9-DA97-440C-92D9-EBAE6471DE1FQ33700482-1E4CA377-2888-4DFD-B0EE-D33E2766FAA2Q33700482-5BFC7447-9C22-4967-B734-1DF37ED269EDQ33707196-5E2713AF-B277-4451-8D9F-CB92817BAEF8Q34037698-7434D7A8-B5A6-4035-A801-4549F4B4412DQ34104493-679A3D68-061A-478E-9A46-77B553A5C394Q34135528-E983C5CC-4AE1-4926-879A-E1759AEFCF23Q34353174-0BF65764-CC02-44C8-A8F1-4126C2810E5AQ34376920-590019A2-CD57-4A1B-A94E-3177FE7B96B7Q34457367-81EAAFA2-C803-496F-9A41-43C87BD73EC0Q34802527-C807B6B0-810E-4EE7-9018-678732F42753Q34993023-0828EAE7-956B-4168-BAD9-14092F40480AQ35231447-921E4610-EDE8-4F12-830A-BAE774CD8528Q35237526-D41B9389-46FA-4562-A7E1-C588D16AF290Q35913384-1A99E847-3080-4229-AE84-817CDA093F2FQ35977804-82EA6348-E096-4AE1-80D7-56A7B8F0DB2EQ36502944-54F34F75-CD01-4D71-9A14-BB785E2FB28EQ36817881-FFEA1772-0A5C-469F-A193-E7FE3124D200Q36922108-F0320400-8982-48AE-B1EB-04916D758180Q36987718-C40E203E-EB74-457A-BC5B-F08808C0FB15Q37089020-D39AB104-8F3C-4A90-AFB8-FA7EB3163D71Q37552414-1B980703-9212-46A8-A757-3B06253EB089Q37619600-B8B9FC19-59F6-435B-9CF0-74DD77AD3E28Q37719383-18B82E5A-403E-4DC5-81F4-FEA95E3B387CQ38113220-94A195B4-BF0C-4C48-BA09-34B912F3497BQ38244965-B41937D9-9B18-44A8-A73C-E2CBCC6D41DAQ38249070-10F7F70B-445E-4509-8B1A-538516B5C060Q38614249-67470F55-C553-4454-A0FE-A9069334FACFQ38807021-0AEBEC93-C0D8-4F2E-9080-34F2DA912D43Q38812588-14DD05A7-F215-4008-A282-87A877D1E14CQ38832584-9B89198B-EA13-4707-A6D0-5275972D72AEQ39120148-55C2EAC8-42FA-4DF3-A828-2B9BAE157152Q39395085-6CA2BCB6-FF05-4056-B95D-F7345E1880F0Q39673531-0C6BFCDE-5C5B-4463-A5CB-F0AD19F9DE78Q40203774-CA3E0098-78AA-499D-AADB-7FE295C1B5C5Q40324354-B5031C90-796E-4062-A49E-4BB5089A0B5E
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jesper B. Andersen
@ast
Jesper B. Andersen
@en
Jesper B. Andersen
@es
Jesper B. Andersen
@nl
Jesper B. Andersen
@sl
type
label
Jesper B. Andersen
@ast
Jesper B. Andersen
@en
Jesper B. Andersen
@es
Jesper B. Andersen
@nl
Jesper B. Andersen
@sl
altLabel
Jesper Bøje Andersen
@en
prefLabel
Jesper B. Andersen
@ast
Jesper B. Andersen
@en
Jesper B. Andersen
@es
Jesper B. Andersen
@nl
Jesper B. Andersen
@sl
P106
P1153
26540929900
P31
P496
0000-0003-1760-5244